| Patents for A61P 13 - Drugs for disorders of the urinary system (56,135) |
|---|
| 04/17/2003 | US20030073693 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto |
| 04/17/2003 | US20030073692 Anticancer agents; viricides; Alzheimer's diseases |
| 04/17/2003 | US20030073684 Respiratory system disorders; cardiovascular disorders; hemorrhage therapy |
| 04/17/2003 | US20030073677 Synergistic mixtures; anticancer agents; 2-(2 -methyl-4-thiazolyl)ethenyl)-4,17-dioxabicyclo(14.1.0)heptadecane-5,9 -dione or 4-aza-17-oxabicyclo(14.1.0) heptadecane-5,9-dione or 1-aza-13-cyclohexadecene-2,6-dione or 1-oxa-13-cyclohexadecene-2,6-dione derivatives |
| 04/17/2003 | US20030073669 N-heterocyclic derivatives as NOS inhibitors |
| 04/17/2003 | US20030073628 Guanylate cyclase receptor agonists for the treatment of tissue inflammation and carcinogenesis |
| 04/17/2003 | US20030073218 Enzyme inhibitor for us in the treatment and prevention of tumors |
| 04/17/2003 | US20030073167 DNA encoding SNORF36 receptors |
| 04/17/2003 | US20030072822 Methods for treating disorders using plant extracts |
| 04/17/2003 | US20030072789 For towelette or wipes useful for feminine cleansing |
| 04/17/2003 | US20030072763 Absorb in the low- energy, ultraviolet, visible, or near-infrared (NIR) region of the electromagnetic spectrum that are used for the phototherapy of tumors and other lesions |
| 04/17/2003 | CA2463339A1 Controlled release drug delivery composition comprising polycationic polymer and negatively charged pharmacologically active compound |
| 04/17/2003 | CA2463198A1 Pyrrolidinone derivatives |
| 04/17/2003 | CA2462892A1 Human 3 relaxin |
| 04/17/2003 | CA2462881A1 Intraorally disintegrating valdecoxib compositions prepared by spray drying process |
| 04/17/2003 | CA2462876A1 Compositions for and methods of treating and preventing sirs/sepsis |
| 04/17/2003 | CA2462862A1 3,4-di-substituted maleimide compounds as cxc-chemokine receptor antagonists |
| 04/17/2003 | CA2461064A1 Inhibition of stat-1 |
| 04/17/2003 | CA2458456A1 Heterocyclic compounds for use in the treatment of disorders of the urinary tract |
| 04/16/2003 | EP1302463A1 Medicine comprising dicyanopyridine derivative |
| 04/16/2003 | EP1302460A1 Indolecarboxylic compounds and their use as pharmaceutical compounds |
| 04/16/2003 | EP1302201A1 Pharmaceutical composition improved in peroral absorbability |
| 04/16/2003 | EP1301598A2 Cell cycle proteins and mitosis-associated molecules |
| 04/16/2003 | EP1301595A2 G-protein coupled receptors |
| 04/16/2003 | EP1301535A2 G-protein coupled receptors |
| 04/16/2003 | EP1301524A1 B7-like polynucleotides, polypeptides, and antibodies |
| 04/16/2003 | EP1301507A2 Mannich base prodrugs of 3 - (pyrrol-2-ylmethylidene)-2-indolinone derivatives and their use as modulators of protein kinases |
| 04/16/2003 | EP1301500A1 Nitrosated and nitrosylated taxanes, compositions and methods of use |
| 04/16/2003 | EP1301497A1 Colchinol derivatives as vascular damaging agents |
| 04/16/2003 | EP1301484A2 Capsaicin receptor ligands |
| 04/16/2003 | EP1301482A1 Cyclic amine phenyl beta-3 adrenergic receptor agonists |
| 04/16/2003 | EP1301476A1 New combination of serotonin agonist (5ht2) and antagonist (5ht6)as pharmaceutical formulation |
| 04/16/2003 | EP1301207A2 Compositions for treating bacterial infections, containing an oxazolidinone compound, sulbactam and and ampicillin |
| 04/16/2003 | EP1301195A2 Pharmaceutical use of fibulin-1 |
| 04/16/2003 | EP1056449B1 20-hete antagonists and agonists |
| 04/16/2003 | EP1024807B1 Use of the compound 2-methoxyphenyl-1-methyl-5p-methylbenzoyl-pyrrol-2-acetamido acetate for the production of an anti-inflammatory drug with prevention of gastric hypersecretion and renal impairment |
| 04/16/2003 | EP0977565B1 Pharmaceutical composition comprising a tricyclic compound with enhanced stability, absorbability and low irritation potential |
| 04/16/2003 | EP0801554B1 Formulations and methods for reducing skin irritation |
| 04/16/2003 | EP0649414B1 Opioid diarylmethylpiperazines and piperidines |
| 04/16/2003 | CN1411458A Saccharin derivatives as orally active elastase inhibitors |
| 04/16/2003 | CN1411447A Polymorphic crystalline forms of celecoxib |
| 04/16/2003 | CN1411446A Ortho-sulfonamido aryl hydroxamic acids, process for their preparation and their use as matrix metalloproteinase inhibitors |
| 04/16/2003 | CN1410076A Application of fur seal oil in preparation of medicine for treating prostatauxe |
| 04/16/2003 | CN1105723C Spirocyclic metalloprotease inhibitors |
| 04/16/2003 | CN1105644C Polyorganosiloxane sheet and surgical bandage manufacted using same |
| 04/16/2003 | CN1105576C Insulin analog formulation |
| 04/16/2003 | CN1105574C Therapeutic uses of bactericidal/permeability increasing protein products |
| 04/15/2003 | US6548671 Quinoxalinyl amide derivatives |
| 04/15/2003 | US6548667 For prevention and treatment of diseases caused by overexpression and overactivation of matrix metalloproteinase |
| 04/15/2003 | US6548665 Asymmetric synthesis of a key intermediate for making benazepril and analogues thereof |
| 04/15/2003 | US6548638 Peptoid and nonpeptoid containing α-keto oxadiazoles as serine protease inhibitors |
| 04/15/2003 | US6548547 Sulfonylamino carboxylic acid N-arylamides as guanylate cyclase activators |
| 04/15/2003 | US6548526 Isothiazole derivatives useful as anticancer agents |
| 04/15/2003 | US6548522 N-substituted 2,2-diphenylacetamide or N-substituted 2-phenyl-2-pyridinylacetamide |
| 04/15/2003 | US6548520 Substituted imidazoles having anti-cancer and cytokine inhibitory activity |
| 04/15/2003 | US6548503 Pyridin-4-yl or pyrimidin-4-yl substituted pyrazines |
| 04/15/2003 | US6548500 Treating a cell adhesion-mediated diseases such as multiple sclerosis, asthma, atherosclerosis, rheumatoid arthritis, meningitis, comprising administering to a warm blooded animal a nitrogen atoms containing bicyclic compound |
| 04/15/2003 | US6548483 Nutritional preparation comprising ribose and medical use thereof |
| 04/15/2003 | US6548481 A salt form of a dipeptide compound formed from an amino acid and a thiazolidine or pyrrolidine group, and the salts are selected from acetates, tartrates, fumarates, succinates, phosphates and sulfates |
| 04/15/2003 | US6548475 Use of the KAL protein and treatment with the KAL protein in treatment of retinal, renal, neuronal and neural injury |
| 04/15/2003 | US6548279 For polypeptides able to catalyze the enzymatic function of superoxide dismutase, carbonic anhydrase, or HIV protease |
| 04/15/2003 | US6548062 Preferred for the treatment of prostate or pancreatic cancer. |
| 04/15/2003 | CA2130516C New 11-benzaldoxime-estradiene derivatives, processes for their production and pharmaceuticals containing these substances |
| 04/15/2003 | CA2084775C Method of treating human prostatic adenocarcinoma |
| 04/15/2003 | CA2053208C Hydroxyalkylquinoline ether acids as leukotriene antagonists |
| 04/15/2003 | CA2048242C 4-amino-4-steroids and their use as 5.alpha.-reductase inhibitors |
| 04/11/2003 | WO2002032899A1 Novel anticholinergic agents that can be used as medicaments and method for the production thereof |
| 04/11/2003 | WO2002032898A2 Novel anticholinergics, method for the production thereof and use thereof as medicaments |
| 04/11/2003 | WO2002030934A1 Substituted 3.4-dihydro-pyrimido[1,2-a]pyrimidines and 3.4-dihydropyrazino[1,2-a]pyrimidines |
| 04/11/2003 | CA2425685A1 Substituted 3.4-dihydro-pyrimido[1,2-a]pyrimidines and 3.4-dihydropyrazino[1,2-a]pyrimidines |
| 04/10/2003 | WO2003029437A2 Secreted proteins |
| 04/10/2003 | WO2003029424A2 Novel proteins and nucleic acids encoding same |
| 04/10/2003 | WO2003029410A2 METHODS OF USING 69039, A NOVEL HUMAN Na/Ca EXCHANGER FAMILY MEMBER |
| 04/10/2003 | WO2003029254A1 Process for preparation of tricyclic compounds |
| 04/10/2003 | WO2003029245A1 Spiro-hydantoin compounds useful as anti-inflammatory agents |
| 04/10/2003 | WO2003029242A1 NF-λB INHIBITORS |
| 04/10/2003 | WO2003029200A2 Compounds useful as reversible inhibitors of cysteine proteases |
| 04/10/2003 | WO2003029199A1 Benzene derivatives, process for preparing the same and use thereof |
| 04/10/2003 | WO2003029187A1 Quaternary ammonium salts of omega-aminoalkylamides of r-2-aryl-propionic acids and pharmaceutical compositions containing them |
| 04/10/2003 | WO2003028726A1 Quinoline derivatives as neuropeptide y antagonists |
| 04/10/2003 | WO2003028720A1 Aminoindazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions containing them |
| 04/10/2003 | WO2003028705A1 Pharmaceutical compositions comprising colloidal silicon dioxide |
| 04/10/2003 | WO2003028600A1 Wipe formulation |
| 04/10/2003 | WO2003028527A2 Diagnostic or therapeutic somatostatin or bombesin analog conjugates and uses thereof |
| 04/10/2003 | WO2003028473A1 Process for the fractionation of oilseed press cakes and meals |
| 04/10/2003 | WO2003002092A3 Controlled release composition comprising lactic acid polymer and hydroxynaphthoic acid, and method of producing the same |
| 04/10/2003 | WO2002100417A3 Use of glycosaminoglycans for the treatment of hiv-associated nephropathy |
| 04/10/2003 | WO2002094203A3 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |
| 04/10/2003 | WO2002094189A3 Compositions and methods for treating or preventing convulsions or seizures |
| 04/10/2003 | WO2002081668A8 Desaturase genes and uses thereof |
| 04/10/2003 | WO2002071827A3 Retinoid x receptor modulators |
| 04/10/2003 | WO2002059083A3 Novel compounds |
| 04/10/2003 | WO2002057460A3 Polynucleotides encoding human phosphatases |
| 04/10/2003 | WO2002008396A3 Human proteases |
| 04/10/2003 | US20030069430 Substituted oxindole derivatives as protein tyrosine and as protein serine/threonine kinase inhibitors and compositions and methods of treating chemotherapy and radiation therapy side effects |
| 04/10/2003 | US20030069429 Piperidine and pyrrolidine derivatives comprising a nitric oxide donor for treating stress |
| 04/10/2003 | US20030069406 Nucleotide sequences coding polypeptide for use in the diagnosis and treatment of blood disorders |
| 04/10/2003 | US20030069314 Therapy for incotinence |
| 04/10/2003 | US20030069312 Nitromethyl ketones, process for preparing them and compositions containing them |
| 04/10/2003 | US20030069301 Method, compositions and kits for increasing the oral bioavailability of pharmaceutical agents |